Legislation

This Therapeutic Goods Order constitutes a standard for therapeutic vaping substances, therapeutic vaping substance accessories, therapeutic vaping kits and goods in a therapeutic vaping pack.

This Therapeutic Goods Order sets out general and specific requirements relating to all biologicals, human musculoskeletal tissue products, human cardiovascular tissue products, human ocular tissue products, human skin products and human amnion products.

This Specification facilitates the release of specified therapeutic goods information held by the TGA in the database known as the System for Australian Recall Actions (SARA), relating to recall actions involving therapeutic goods.

This Instrument amends the Therapeutic Goods Advertising Code to include a reference to the Therapeutic Goods (Restricted Representations—COVID-19 Vaccines) Permission 2022.

This Instrument contains the Therapeutic Goods Advertising Code. The Code specifies a range of requirements to protect the Australian public from the personal and public health risks associated with unethical, inaccurate or misleading advertising practices relating to the advertising of therapeutic goods.

This Specification facilitates the public release of therapeutic goods information that has been provided to the TGA by a sponsor in an Online Notification Form that relates to the transition of a medical device from certain European Directives to the new EU medical devices regulation.

This Determination specifies the kinds of vaping goods which may be supplied or possessed by specified persons or classes of persons and under what circumstances or conditions.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.